EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Beneficial vascular effects of oral phosphatidylserine supplementation in type 2 diabetes

Neil J McMillan iD, Marc A Augenreich iD, Francisco I Ramirez-Perez iD, Gavin Power, Katherine Burr, Olubodun M Lateef iD, Manikandan Nagarajan iD, Christopher A Foote, Natnicha Imkaew iD, Thomas J Jurrissen, Yoskaly Lazo-Fernandez iD, Edgar E Betancourt-Cortes und 5 weitere

Journal of Applied Physiology · 01.07.2026 · 141 (1) · 130-148

DOI: 10.1152/japplphysiol.00281.2026 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Applied Physiology, erschienen am 01.07.2026. Verfasst von Neil J McMillan und 16 weiteren Autor:innen. Beteiligte Einrichtung: NextGen Precision Health, University of Missouri, Columbia, Missouri, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Phosphatidylserines. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Sao Paulo Research Foundation, American Heart Association (AHA), NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sheddase activity of a disintegrin and matrix metalloproteinase 17 (ADAM17) is augmented in the setting of type 2 diabetes (T2D), likely contributing to the shedding of the extracellular domain of the insulin receptor on the arterial endothelial surface, leading to endothelial dysfunction. Findings from this work support the notion that exogenous phosphatidylserine can inhibit arterial ADAM17 activity and improve markers of vascular health in diabetic mice and humans with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2PhosphatidylserinesAnimalsHumansMaleMiceInsulin ResistanceVasodilationADAM17 ProteinAdministration, OralDietary SupplementsVascular StiffnessDouble-Blind MethodMiddle AgedEndothelium, VascularInsulinMice, Inbred C57BLEndothelial CellsFemale

Stichwörter der Autor:innen

diabetesphosphatidylserinevascular function

Substanzen

PhosphatidylserinesADAM17 ProteinInsulinADAM17 protein, human

Autor:innen und Institutionen

  • NextGen Precision Health, University of Missouri, Columbia, Missouri, United States.
  • Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri, United States.
  • Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, Missouri, United States.
  • Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, Missouri, United States.
  • Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
  • Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, Missouri, United States.

ORCID-Profile: Neil J McMillan, Marc A Augenreich, Francisco I Ramirez-Perez, Olubodun M Lateef, Manikandan Nagarajan, Natnicha Imkaew, Yoskaly Lazo-Fernandez, Larissa Ferreira-Santos, Camila Manrique-Acevedo, Luis A Martinez-Lemus, Jaume Padilla

Förderung

  • Sao Paulo Research Foundation
  • American Heart Association (AHA)
  • NHLBI NIH HHS
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)

Zitieren

APA

McMillan, N. J., Augenreich, M. A., Ramirez-Perez, F. I., Power, G., Burr, K., Lateef, O. M., Nagarajan, M., Foote, C. A., Imkaew, N., Jurrissen, T. J., Lazo-Fernandez, Y., Betancourt-Cortes, E. E., Ferreira-Santos, L., Beltran-Ornelas, J. H., Manrique-Acevedo, C., Martinez-Lemus, L. A., & Padilla, J. (2026). Beneficial vascular effects of oral phosphatidylserine supplementation in type 2 diabetes. Journal of Applied Physiology, 141(1), 130-148. https://doi.org/10.1152/japplphysiol.00281.2026

Vancouver

McMillan NJ, Augenreich MA, Ramirez-Perez FI, Power G, Burr K, Lateef OM, et al. Beneficial vascular effects of oral phosphatidylserine supplementation in type 2 diabetes. Journal of Applied Physiology. 2026;141(1):130-148. doi:10.1152/japplphysiol.00281.2026

BibTeX
@article{McMillan2026,
  author = {McMillan, Neil J and Augenreich, Marc A and Ramirez-Perez, Francisco I and Power, Gavin and Burr, Katherine and Lateef, Olubodun M and Nagarajan, Manikandan and Foote, Christopher A and Imkaew, Natnicha and Jurrissen, Thomas J and Lazo-Fernandez, Yoskaly and Betancourt-Cortes, Edgar E and Ferreira-Santos, Larissa and Beltran-Ornelas, Jesus H and Manrique-Acevedo, Camila and Martinez-Lemus, Luis A and Padilla, Jaume},
  title = {Beneficial vascular effects of oral phosphatidylserine supplementation in type 2 diabetes},
  journal = {Journal of Applied Physiology},
  year = {2026},
  volume = {141},
  number = {1},
  pages = {130--148},
  doi = {10.1152/japplphysiol.00281.2026}
}
Kostenlos starten →